Stay updated on Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new Revision: v3.6.3 was added to the record history. The previous Revision: v3.6.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-06-30T02:40:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a note that the study is not recruiting participants. The revision tag was updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-15T20:22:45.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision label at the bottom of the page updated from v3.5.4 to v3.5.5, signaling a new platform revision was deployed. This change does not modify study data, text, or core functionality visible to users.
    Difference
    0.1%
    Check dated 2026-06-08T16:24:36.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the record history, and the previous revision entry v3.5.3 was removed, indicating an update to the study record's versioning in the history view.
    Difference
    0.1%
    Check dated 2026-05-18T03:58:04.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page’s interface revision label was updated from **v3.5.0** to **v3.5.3**, indicating a minor software/version change rather than a change to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-26T15:31:36.000Z thumbnail image
  7. Check
    104 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T19:49:43.000Z thumbnail image

Stay in the know with updates to Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.